A practical reference on AOD-9604: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-04-25. Anything still debated is marked as such rather than presented as settled.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
=== Early years === Established in 1903 in Singapore, Cold Storage started as a small depot storing and selling mainly frozen meat. Cold Storage was then known as the Singapore Cold Storage Company, and was the main manufacturer of ice in Singapore. Taking advantage of the booming ice manufacturing and refrigeration business, Cold Storage ventured into the ice cream business. In 1923, a small factory was set up at the Borneo Wharf of the Harbourfront district to manufacture ice cream under the Paradise brand. In its early days, the company's primary concern was to have a quick and profitable turnover of its imported meats and range of products. Cold Storage later shifted from counter-service to self-service, introducing the supermarket to Singapore.
When visitors enter the museum, a series of four 5-minute videos recount the history of the Arabia's sinking and excavation. An additional 14-minute film called The Fall and Rise of the Steamboat Arabia may also be viewed in the theater. Next, guests view the artifacts on display, as well as an open preservation lab where staff members work on cleaning the many artifacts in storage. Restoring the items can be a lengthy process—even a small nail can take over an hour. Other items, like shoes and boots, may take up to three months to preserve. Finally, visitors walk a 171-foot-long full-scale reproduction of the Arabia's main deck, where they can see archival footage of the excavation process and more information about its history, along with the original boilers, engine, anchor, and the skeleton of a mule. Also on display are the 6-ton stern and a reconstructed paddle wheel. The museum additionally offers a gift shop, meeting space, and after-hours event rental.
== Business == The company manufactures a variety of GPS (Global Positioning System) trackers intended for use in vehicles and other mobile assets. It also offers an Internet-based subscription service that gives clients access to 5- or 10-second updates around the clock from each installed GPS tracker. The system collects and stores data from each unit on a 24/7 basis, and can generate reports showing the activity of each vehicle during a specified time frame. The system can be configured to transmit alerts to the account owner if certain user-defined conditions are detected, such as a monitored vehicle exceeding acceptable speeds or entering/exiting a specific area.
Sources: en.wikipedia.org
=== Tertiary structure === GALE structure has been resolved for a number of species, including E. coli and humans. GALE exists as a homodimer in various species. While subunit size varies from 68 amino acids (Enterococcus faecalis) to 564 amino acids (Rhodococcus jostii), a majority of GALE subunits cluster near 330 amino acids in length. Each subunit contains two distinct domains. An N-terminal domain contains a 7-stranded parallel β-pleated sheet flanked by α-helices. Paired Rossmann folds within this domain allow GALE to tightly bind one NAD+ cofactor per subunit. A 6-stranded β-sheet and 5 α-helices comprise GALE's C-terminal domain. C-terminal residues bind UDP, such that the subunit is responsible for correctly positioning UDP-glucose or UDP-galactose for catalysis.
Eosin is the name of several fluorescent acidic compounds which bind to and form salts with basic, or eosinophilic, compounds like proteins containing basic amino acid residues such as histidine, arginine and lysine, and stains them dark red or pink as a result of the actions of bromine on eosin. In addition to staining proteins in the cytoplasm, it can be used to stain collagen and muscle fibers for examination under the microscope. Structures that stain readily with eosin are termed eosinophilic. In the field of histology, Eosin Y is the form of eosin used most often as a histologic stain.
In Japan, Mister Donut's "signature" is the "Pon de Ringu, with its cartoon lion mascot." The Japanese stores also sell the "pon de ring, Mister Donut's signature item that's made of a connected circle of dough balls." Pon de ring varieties include the pon de angel, which is cream-filled, and the pon de kokuto, or a pon de ring with brown sugar.
Sources: en.wikipedia.org
A soldier of FC Wing 177 was killed by insurgents in Bajaur District and another FC soldier was killed in South Waziristan, moreover an Elite Force cop was killed in Hangu District. TTP, however claimed to have conducted 16 attacks in South Waziristan, North Waziristan, Karak, Kohat, Bajaur, Peshawar, and Harnai on the day, claiming to have killed 11 Pakistani personnel. A drone strike in Mirali injured two civilians. On 2 July, Pakistani forces intercepted a drone targeting the 134 Wing of Pishin Scouts. A girls school was damaged in an insurgent attack in Bannu District, while an IED targeting a bridge was also neutralized. A drone attack in Bajaur allegedly intended at a Pakistani position, killed three civilians and wounded eight more. Two policemen were killed and one was wounded in a militant ambush in Mohmand District. Khalid Masood, a TTP commander was assassinated by "unidentified attackers" inside Afghanistan in Ghazni District. On 3 July, Pakistani forces killed three insurgents in Bajaur District, while TTP claimed to have assassinated a suspected Pakistani spy in Khyber District. JuA announced its formal split from the TTP. Two FC soldiers were killed in a Taliban sniper attack on the Do Jando border Post in Khyber District. An IED was also defused by Pakistani forces in Wana. On 5 July, heavy fighting between Pakistani and Afghan troops took place in Khyber District, following cross border fire from Afghanistan which wounded three Pakistani soldiers.
Debate about whether orgasm was even necessary for women began in the Victorian era, and Freud's 1905 theory about the immaturity of clitoral orgasms (see above) negatively affected women's sexuality throughout most of the 20th century. Toward the end of World War I, a maverick British MP named Noel Pemberton Billing published an article entitled "The Cult of the Clitoris", furthering his conspiracy theories and attacking the actress Maud Allan and Margot Asquith, wife of the prime minister. The accusations led to a sensational libel trial, which Billing eventually won; Philip Hoare reports that Billing argued that "as a medical term, 'clitoris' would only be known to the 'initiated', and was incapable of corrupting moral minds". Jodie Medd argues regarding "The Cult of the Clitoris" that "the female non-reproductive but desiring body [...] simultaneously demands and refuses interpretative attention, inciting scandal through its very resistance to representation". From the 18th to the 20th century, especially during the 20th, details of the clitoris from various genital diagrams presented in earlier centuries were omitted from later texts. The full extent of the clitoris was alluded to by Masters and Johnson in 1966, but in such a muddled fashion that the significance of their description became obscured; in 1981, the Federation of Feminist Women's Health Clinics (FFWHC) continued this process with anatomically precise illustrations identifying 18 structures of the clitoris.
In the 1930s and later, epidemiologists from Japan, the UK, and the US, including Richard Doll and various others, reported greater rates of death from lung cancer following occupational exposure to PAH-rich environments among workers in coke ovens and coal carbonization and gasification processes.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.